Bone Biologics (BBLG) Treasury Shares (2015 - 2022)
Bone Biologics (BBLG) reported Treasury Shares of $13083.0 for Q1 2022, down 98.48% quarter-over-quarter from $862182.0 in Q2 2018.
Bone Biologics (BBLG) Treasury Shares (2015 - 2022) Analysis & Trends
Bone Biologics (BBLG) has 5 years of Treasury Shares data on file, last reported at $13083.0 in Q1 2022.
- Treasury Shares for Q1 2022 came in at $13083.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2022 was $13083.0 (changed N/A YoY), and the FY2017 annual result was $1.0 million, down 90.12% from the prior year.
- Treasury Shares eased to $13083.0 in Q1 2022 per BBLG's latest filing, from $862182.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $9.2 million in Q1 2018 and troughed at $13083.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 13,083.00 |
| Mar 31, 2022 | 13,083.00 |
| Jun 30, 2018 | 862,182.00 |
| Jun 30, 2018 | 862,182.00 |
| Mar 31, 2018 | 9.24 Mn |
| Mar 31, 2018 | 9.24 Mn |
| Dec 31, 2017 | 1.03 Mn |
| Dec 31, 2017 | 1.03 Mn |
| Dec 31, 2016 | 10.39 Mn |
| Dec 31, 2016 | 10.39 Mn |
| Dec 31, 2015 | 9.78 Mn |
| Dec 31, 2015 | 9.78 Mn |